Antimicrobial Agents Practice Questions

Q: Which of the following aminoglycosides carries the highest risk of neuromuscular blockade?

Neomycin. ### Explanation **Correct Answer: B. Neomycin** **Mechanism of Neuromuscular Blockade (NMB):** Aminoglycosides can induce neuromuscular blockade by inhibiting the pre-junctional release of **Acetylcholine (ACh)** and reducing the sensitivity of the post-junctional nicotinic receptors. This effect is primarily due to the competitive inhibition of **Calcium ions** at the presynaptic nerve terminal. Among all aminoglycosides, **Neomycin** is the most potent inhibitor of ACh release, followed closely by Kanamycin [1]. Because of this high toxicity profile, Neomycin is never administered parenterally; it is restricted to topical use or oral administration for bowel preparation/hepatic coma. **Analysis of Incorrect Options:** * **D. Kanamycin:** While Kanamycin carries a significant risk of NMB (second only to Neomycin), it is clinically less potent in this regard than Neomycin [1]. The use of kanamycin has declined because it is among the most toxic aminoglycosides [1]. * **A. Tobramycin & C. Amikacin:** These are commonly used parenteral aminoglycosides. While they still carry a theoretical risk of NMB, their potential to cause respiratory paralysis is significantly lower than that of Neomycin or Kanamycin. **NEET-PG High-Yield Clinical Pearls:** 1. **Order of Potency for NMB:** Neomycin > Kanamycin > Amikacin > Gentamicin > Tobramycin. 2. **Reversal:** Aminoglycoside-induced NMB is best reversed by **Intravenous Calcium Gluconate** (antagonizes the calcium-blocking effect). Neostigmine may also be used but is less reliably effective [2]. 3. **Contraindication:** Aminoglycosides are strictly contraindicated in patients with **Myasthenia Gravis**, as they can precipitate a severe myasthenic crisis. 4. **Drug Interaction:** Risk increases significantly when used concurrently with skeletal muscle relaxants (e.g., Succinylcholine or Vecuronium) [3].

Q: Which is the longest acting oral sulfonamide?

Sulphadoxine. **Explanation:** Sulfonamides are classified based on their pharmacokinetic profile, specifically their duration of action, which is determined by their rate of renal excretion and protein binding. **Why Sulphadoxine is correct:** **Sulphadoxine** is categorized as an **ultra-long-acting sulfonamide**. It has an exceptionally long half-life of approximately **7 to 9 days (170–200 hours)**. This is due to its high degree of plasma protein binding and slow renal clearance. Because of this prolonged action, it is not used for routine infections but is primarily used in combination with Pyrimethamine (Fansidar) for the prophylaxis and treatment of chloroquine-resistant *Plasmodium falciparum* malaria. **Analysis of Incorrect Options:** * **Sulphadiazine:** This is a **short-acting** sulfonamide with a half-life of about 10 hours. It is commonly used in the treatment of UTI and, in combination with pyrimethamine, is the first-line treatment for Toxoplasmosis. * **Sulphacetamide:** This is a highly soluble sulfonamide used primarily **topically** in the eye for bacterial conjunctivitis. It is not used for its systemic long-acting properties. * **Mafenide:** This is a **topical** sulfonamide used primarily in burn dressings to prevent infection (especially *Pseudomonas*). It is not administered orally for systemic effect and is known for causing metabolic acidosis as a side effect. **High-Yield NEET-PG Pearls:** * **Mechanism of Action:** Sulfonamides are structural analogs of PABA; they competitively inhibit **Dihydropteroate Synthase**. * **Shortest acting sulfonamide:** Sulfisoxazole. * **Drug of choice for Nocardiosis:** Sulfonamides (usually Cotrimoxazole). * **Key Side Effect:** Stevens-Johnson Syndrome (SJS) and Crystalluria (prevented by alkalinizing urine and increasing fluid intake).

Q: Ivermectin acts by?

Activation of Glutamate-gated Chloride channels. **Mechanism of Action: Ivermectin** **Correct Answer: C. Activation of Glutamate-gated Chloride channels** Ivermectin is a broad-spectrum anthelmintic agent that works by binding selectively and with high affinity to **glutamate-gated chloride ion channels** located in invertebrate nerve and muscle cells. This binding increases the permeability of the cell membrane to chloride ions, leading to **hyperpolarization** of the nerve or muscle cell. The result is tonic paralysis and eventual death of the parasite. In humans, ivermectin does not easily cross the blood-brain barrier, which protects our GABA receptors from similar effects. **Analysis of Incorrect Options:** * **A. Inhibition of pyruvate ferredoxin oxidoreductase:** This is the mechanism of action for **Nitazoxanide** and **Metronidazole** (in anaerobic bacteria/protozoa like *Giardia* and *Entamoeba*). It interferes with anaerobic energy metabolism. * **B. Inhibition of Nicotinic Acetylcholine receptor:** This describes the action of neuromuscular blockers or certain insecticides. In contrast, **Pyrantel pamoate** acts as a nicotinic receptor *agonist* (depolarizing neuromuscular blocker) in helminths. * **D. Inhibition of heme polymerase:** This is the mechanism of **Chloroquine** and other aminoquinolines. It prevents the detoxification of heme into hemozoin in malaria parasites, leading to toxic heme accumulation. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Strongyloidiasis, Onchocerciasis (River blindness), Scabies (oral), and *Larva currens*. * **Mazzotti Reaction:** A severe immune response (fever, rash, hypotension) seen after treating Onchocerciasis with ivermectin due to the rapid death of microfilariae. * **Safety:** Contraindicated in conditions where the blood-brain barrier is compromised (e.g., meningitis, African Sleeping Sickness).

Q: Which of the following drugs is useful in the treatment of infection by Mycobacterium avium complex?

Clarithromycin. **Explanation:** *Mycobacterium avium* complex (MAC) is a group of non-tuberculous mycobacteria (NTM) that frequently causes opportunistic infections in immunocompromised patients, particularly those with HIV/AIDS (CD4 count <50 cells/mm³). **Why Clarithromycin is correct:** Clarithromycin (or Azithromycin) is the **drug of choice** for both the prophylaxis and treatment of MAC infections. Macrolides inhibit protein synthesis by binding to the 50S ribosomal subunit. For active MAC infection, Clarithromycin is typically used in combination with Ethambutol and sometimes Rifabutin to prevent the emergence of resistance. **Why the other options are incorrect:** * **Isoniazid (A):** While it is a primary (first-line) drug for *M. tuberculosis*, MAC is intrinsically resistant to Isoniazid due to differences in the cell wall and metabolic pathways. * **Cycloserine (C):** This is a second-line drug used for Multidrug-Resistant Tuberculosis (MDR-TB). It has minimal clinical utility against MAC. * **Rifampicin (D):** Although Rifampicin is a first-line anti-TB drug, it is generally less effective against MAC than its derivative, **Rifabutin**, which is preferred in MAC regimens due to higher potency and fewer drug interactions in HIV patients. **High-Yield Clinical Pearls for NEET-PG:** * **Prophylaxis:** Start Azithromycin or Clarithromycin in HIV patients when CD4 count falls below **50 cells/mm³**. * **Treatment Regimen:** The standard "triple therapy" for MAC includes **Clarithromycin + Ethambutol + Rifabutin**. * **Side Effect:** Monitor for metallic taste and GI upset with Clarithromycin; monitor for uveitis and orange discoloration of secretions with Rifabutin.

Q: What is the recommended dose and duration of benzathine penicillin G for the prophylaxis of rheumatic fever?

1.2 MU every 4 weeks. **Explanation:** **1. Understanding the Correct Answer (Option B):** Rheumatic fever prophylaxis aims to prevent recurrent Group A Streptococcal (GAS) pharyngitis, which can trigger a recurrence of rheumatic fever. **Benzathine Penicillin G** is the drug of choice because it is a long-acting repository form that releases penicillin slowly into the systemic circulation. The standard recommended dose for secondary prophylaxis in adolescents and adults (or children >27 kg) is **1.2 million units (MU) administered intramuscularly every 4 weeks.** In high-risk situations or areas with high endemicity, the frequency may be increased to every 3 weeks, but the standard textbook and guideline answer remains every 4 weeks. **2. Analysis of Incorrect Options:** * **Option A (1.2 MU every 2 weeks):** This frequency is too high for standard prophylaxis and increases the risk of injection site pain and non-compliance without significant added benefit for most patients. * **Options C & D (2.4 MU):** A dose of 2.4 MU is typically reserved for the treatment of **Syphilis** (Primary, Secondary, or Early Latent). Using this dose for rheumatic fever prophylaxis would be excessive and is not supported by clinical guidelines. **3. High-Yield Clinical Pearls for NEET-PG:** * **Duration of Prophylaxis:** * *RF without Carditis:* 5 years or until age 21 (whichever is longer). * *RF with Carditis (no residual heart disease):* 10 years or until age 21 (whichever is longer). * *RF with Carditis + Persistent Valvular Disease:* 10 years or until age 40 (sometimes lifelong). * **Alternative:** If the patient is allergic to penicillin, **Erythromycin (250 mg BD)** or **Azithromycin** is used. * **Route:** Benzathine Penicillin must be given **Intramuscularly (IM)**; accidental IV administration can cause cardiac arrest (Hoigne’s syndrome).

Q: All are features of ethambutol toxicity, except?

Hypercalcemia. **Explanation:** Ethambutol is a first-line bacteriostatic antitubercular drug that acts by inhibiting the enzyme **arabinosyl transferase**, thereby interfering with cell wall synthesis. **Why Hypercalcemia is the correct answer:** Ethambutol is not associated with calcium metabolism. Hypercalcemia is not a side effect of any standard first-line antitubercular drug. In the context of tuberculosis, hypercalcemia is usually a result of the disease process itself (granulomatous inflammation where activated macrophages convert Vitamin D to its active form, calcitriol), rather than the treatment. **Analysis of incorrect options:** * **Retrobulbar Neuritis (Option A):** This is the most characteristic dose-dependent toxicity of Ethambutol. It typically presents as decreased visual acuity. * **Colour Vision Defects (Option B):** Early toxicity often manifests as an inability to distinguish between red and green (red-green color blindness). This is why baseline and periodic ophthalmological examinations are mandatory. * **Hyperuricemia (Option C):** Ethambutol interferes with the renal excretion of uric acid, which can lead to gouty arthritis. This side effect is shared with Pyrazinamide. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Ethambutol:** "E" for **E**ye (Optic neuritis) and **E**xcretion of Uric acid (decreased). * **Safe in Pregnancy:** Ethambutol is considered the safest first-line ATD during pregnancy. * **Renal Adjustment:** It is primarily excreted by the kidneys; therefore, the dose must be adjusted in patients with renal failure. * **Pediatric Use:** Generally avoided in children below 6 years because visual acuity and color vision are difficult to monitor accurately in this age group.

Q: Orange coloured urine is a known side effect of which of the following drugs?

Rifampicin. **Explanation:** **Rifampicin** is the correct answer because it is a highly lipid-soluble macrocyclic antibiotic that undergoes extensive distribution in the body [1]. It is excreted through various body fluids, including urine, sweat, tears, and saliva. Due to its inherent chemical structure (a naphthoquinonic chromophore), it imparts a characteristic **bright orange-red discoloration** to these secretions [2]. **Why the other options are incorrect:** * **Isoniazid (INH):** Its most significant side effects are peripheral neuropathy (prevented by Pyridoxine/Vitamin B6) and hepatotoxicity [1]. It does not cause pigment changes in urine. * **Pyrazinamide:** The most common side effects are hyperuricemia (which can precipitate gout) and hepatotoxicity. * **Ethambutol:** This drug is notorious for causing **optic neuritis**, leading to decreased visual acuity and red-green color blindness. It does not affect urine color. **Clinical Pearls for NEET-PG:** 1. **Patient Counseling:** Patients starting Rifampicin must be warned about orange urine/tears to prevent unnecessary panic and to avoid permanent staining of soft contact lenses [2]. 2. **Mechanism of Action:** Rifampicin inhibits DNA-dependent RNA polymerase [1]. 3. **Enzyme Induction:** Rifampicin is a potent **microsomal enzyme inducer** (CYP450), leading to numerous drug interactions (e.g., reducing the efficacy of oral contraceptives and warfarin). 4. **Mnemonic:** Remember the "4 R's" for Rifampicin: **R**NA polymerase inhibitor, **R**evs up microsomal enzymes, **R**ed-orange secretions, and **R**esistance develops if used alone.

Q: What drug is used in the treatment of resistant gonorrhea?

Spectinomycin. **Explanation:** The correct answer is **Spectinomycin**. **1. Why Spectinomycin is correct:** Spectinomycin is an aminocyclitol antibiotic (chemically related to aminoglycosides) that inhibits protein synthesis by binding to the 30S ribosomal subunit. It is specifically indicated as an alternative treatment for **resistant gonorrhea**, particularly in patients who are allergic to cephalosporins or in cases where *Neisseria gonorrhoeae* is resistant to first-line agents like Ceftriaxone. It is administered as a single intramuscular injection. **2. Why the other options are incorrect:** * **Penicillin:** Once the gold standard, it is no longer used due to the widespread prevalence of **PPNG (Penicillinase-producing *Neisseria gonorrhoeae*)** strains. * **Cotrimoxazole:** This sulfonamide-trimethoprim combination is ineffective against *N. gonorrhoeae* due to high levels of intrinsic and acquired resistance. * **Erythromycin:** While used for *Chlamydia* in pregnancy, it has poor efficacy against *N. gonorrhoeae* and is not recommended for resistant cases. **3. NEET-PG High-Yield Pearls:** * **Current DOC:** The current first-line treatment for uncomplicated gonorrhea is a single dose of **Ceftriaxone (IM)** plus **Azithromycin (Oral)** to cover potential co-infection with *Chlamydia*. * **Spectinomycin Limitation:** It is **ineffective against pharyngeal gonorrhea** and does not treat syphilis or chlamydial infections. * **Mechanism:** Unlike aminoglycosides, spectinomycin is **bacteriostatic** and does not cause significant ototoxicity or nephrotoxicity.

Question 1

Which of the following aminoglycosides carries the highest risk of neuromuscular blockade?

Accepted Answer

Neomycin

Answer

Tobramycin

Answer

Amikacin

Answer

Kanamycin

Question 2

Which is the longest acting oral sulfonamide?

Accepted Answer

Sulphadoxine

Answer

Sulphadiazine

Answer

Sulphacetamide

Answer

Mafenide

Question 3

Ivermectin acts by?

Accepted Answer

Activation of Glutamate-gated Chloride channels

Answer

Inhibition of pyruvate ferridoxin oxidoreductase

Answer

Inhibition of Nicotinic Acetylcholine receptor

Answer

Inhibition of heme polymerase

Question 4

Which of the following drugs is useful in the treatment of infection by Mycobacterium avium complex?

Accepted Answer

Clarithromycin

Answer

Isoniazid

Answer

Cycloserine

Answer

Rifampicin

Question 5

A 50-year-old female with end-stage renal disease (ESRD) develops pulmonary tuberculosis. Which one of the following antitubercular drugs should be used in a reduced dose?

Accepted Answer

Ethambutol

Answer

Rifampicin

Answer

Isoniazid

Answer

Pyrazinamide

Question 6

What is the recommended dose and duration of benzathine penicillin G for the prophylaxis of rheumatic fever?

Accepted Answer

1.2 MU every 4 weeks

Answer

1.2 MU every 2 weeks

Answer

2.4 MU every 2 weeks

Answer

2.4 MU every 4 weeks

Question 7

All are features of ethambutol toxicity, except?

Accepted Answer

Hypercalcemia

Answer

Retrobulbar neuritis

Answer

Colour vision defects

Answer

Hyperuricemia

Question 8

Orange coloured urine is a known side effect of which of the following drugs?

Accepted Answer

Rifampicin

Answer

Isoniazid (INH)

Answer

Pyrazinamide

Answer

Ethambutol

Question 9

What is the drug of choice for the treatment of malaria due to P. vivax in a 25-year-old pregnant female?

Accepted Answer

Chloroquine

Answer

Primaquine

Answer

Sulfadoxine-pyrimethamine

Answer

Quinine

Question 10

What drug is used in the treatment of resistant gonorrhea?

Accepted Answer

Spectinomycin

Answer

Penicillin

Answer

Cotrimoxazole

Answer

Erythromycin

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?